Tirzepatide, sold as Zepbound, produces the largest average weight loss of any prescription weight loss medication currently available. In clinical trials, people taking tirzepatide lost an average of 16.6% of their body weight, compared to 10.5% with semaglutide (Wegovy), the next most effective option. Both are injectable medications, though. If you’re specifically looking for a pill you swallow, the landscape looks different, and the results are more modest.
How Tirzepatide Compares to Semaglutide
A large network meta-analysis covering 19 studies and over 28,000 participants put the two leading medications head to head. Tirzepatide delivered a mean weight reduction of 16.6% from baseline, while semaglutide delivered 10.5%. Both were compared against placebo, and both showed statistically significant results. For context, on a 250-pound starting weight, tirzepatide’s average result translates to roughly 41 pounds lost, versus about 26 pounds with semaglutide.
Both medications are weekly injections, not traditional pills. They work by mimicking gut hormones that regulate appetite and insulin. Semaglutide activates one of these hormone pathways. Tirzepatide activates two: the same one semaglutide targets, plus a second pathway involving a hormone called GIP. Together, these signals act on areas of the brain that control hunger and fullness, reducing appetite and calorie intake. Animal studies also suggest tirzepatide improves insulin sensitivity, which may contribute to its edge in weight loss. Interestingly, human studies haven’t been able to confirm that the extra GIP pathway independently reduces appetite compared to the single-pathway approach. The additional weight loss may come from other metabolic effects researchers are still working to pin down.
The Strongest Oral Medications
If injections aren’t an option, the most effective FDA-approved pill is Qsymia, a combination of phentermine and topiramate. At the highest dose, people in clinical trials lost about 10.9% of their body weight over one year, compared to 1.6% with placebo. A mid-range dose produced about 7.8% weight loss. That makes Qsymia roughly comparable to injectable semaglutide in terms of raw percentages, though the two have never been tested directly against each other in the same trial.
Qsymia works through two different mechanisms. The phentermine component is a stimulant that suppresses appetite. The topiramate component, originally developed for seizures and migraines, also reduces hunger through pathways that aren’t fully understood. It’s approved for long-term use, which sets it apart from phentermine taken alone.
Contrave, a combination of naltrexone and bupropion, is the other major oral option for long-term use. It’s notably less potent. In real-world data from Canadian patients, people lost an average of about 4% of their body weight after six months. Contrave works on the brain’s appetite-regulation and reward pathways, essentially making food less appealing and reducing cravings. It can be a reasonable option for people who also struggle with food-related compulsive behavior, but it doesn’t come close to the weight loss numbers of Qsymia or the injectables.
Phentermine Alone
Phentermine by itself (sold as Adipex-P and Lomaira) is one of the most commonly prescribed weight loss drugs. It’s a stimulant that makes you feel less hungry or full for longer. The catch is that it’s only FDA-approved for short-term use, generally up to 12 weeks, though some doctors prescribe it longer. Because of its limited approved duration, it’s typically used as a jumpstart rather than a long-term solution.
Oral Semaglutide
Semaglutide does come in pill form as Rybelsus, but the currently available oral doses are much lower than the injectable version used for weight loss. At the 14 mg oral dose, people lost about 4.4 kg (roughly 10 pounds) over 26 weeks, compared to 0.5 kg with placebo. That’s meaningful but far less than what injectable semaglutide achieves at higher doses. Rybelsus is approved for type 2 diabetes, not specifically for weight management. Higher-dose oral semaglutide tablets for obesity are in development but not yet widely available.
All FDA-Approved Options at a Glance
The FDA has approved six medications for long-term (chronic) weight management:
- Tirzepatide (Zepbound): weekly injection, ~16.6% average weight loss
- Semaglutide (Wegovy): weekly injection, ~10.5% average weight loss
- Phentermine-topiramate (Qsymia): daily pill, ~9.8 to 10.9% average weight loss
- Naltrexone-bupropion (Contrave): daily pill, ~4% average weight loss
- Liraglutide (Saxenda): daily injection, older GLP-1 drug with lower efficacy than semaglutide
- Orlistat (Xenical/Alli): daily pill, works by blocking fat absorption rather than appetite, with modest results
A seventh medication, setmelanotide (Imcivree), is approved only for people with specific rare genetic disorders confirmed by testing. Four of the six mainstream options are also approved for adolescents ages 12 and older. Short-term drugs like phentermine alone are separate from this list.
Who Qualifies for These Medications
Prescription weight loss medications are generally considered when diet and exercise alone haven’t been enough and your BMI is above 30. If your BMI is above 27 and you also have a weight-related condition like type 2 diabetes or high blood pressure, you may also qualify. These thresholds apply broadly across the approved medications, though individual prescribing decisions depend on your medical history, other medications, and which side effects you’re willing to manage.
Why the “Strongest” Answer Depends on Format
If you’re open to injections, tirzepatide is the clear winner by a wide margin. If you need something you swallow, Qsymia at its highest dose delivers the best results among pills, with weight loss in the 10% range. The gap between the two categories is significant: tirzepatide produces roughly 50 to 70% more weight loss than the best oral option.
Individual results vary considerably from these averages. Some people on tirzepatide lose over 20% of their body weight, while others see more modest changes. The same spread exists with every medication on the list. Factors like starting weight, diet, physical activity, and how long you stay on the medication all influence outcomes. These drugs also work best as part of broader lifestyle changes, not as standalone fixes. Most people regain weight if they stop taking them, which is why the newer medications are approved for ongoing use rather than short courses.